Abstract
AimsThe distinction between intrahepatic cholangiocarcinoma (ICC) and benign bile duct lesions can be challenging. Using our previously identified potential biomarkers for ICC, we examined whether these are useful for the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have